METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation
Advanced Science · 2026-02 · 13 (11)
DOI: 10.1002/advs.202512528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.12.2025. Verfasst von Shuang Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery, Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong,…. Hauptthemen laut MEDLINE: Methyltransferases, Liver Neoplasms, Chemokines, Cholangiocarcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, State Key Program of National Natural Science of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The liver microenvironment is essential to immune surveillance and liver cancer progression. Here, the aim is to identify the role of METTL5, the 18S rRNA m 6 A methyltransferase, in regulating the liver immune microenvironment to promote cancer progression. Liver‐specific Mettl5 knockout (cKO) in mice exhibits increased immune cell infiltration, especially CD3 + and CD4 + T cells. Loss of Mettl5 inhibits intrahepatic cholangiocarcinoma (ICC) progression. By scRNA‐seq analysis, it is found that ICC from both cKO mice and human METTL5 low expression group correlates with increased CD8 + T cells but decreased macrophages, which is associated with better survival. Adoptive transfer of macrophages significantly promotes ICC progression. scRNA‐seq and scTCR‐seq analysis show that cKO mice exhibit reduced immunosuppressive Ms4a7 + C1qa + tumor‐associated macrophages (TAMs) but increased intratumoral IFN‐γ + CD8 + T cell infiltration and expansion. Mechanistically, METTL5‐mediated 18S rRNA m 6 A modification downregulates the mRNA translation of CXCL16 to exclude CD8 + T cells. Knockout of Mettl5 significantly increases CD8 + T cell infiltration in vivo. Combined METTL5 targeting using lipid nanoparticle‐encapsulated siRNA and PD‐1 blockade provokes anti‐tumor immunity to eradicate ICC tumors. Additionally, METTL5 Low human ICC correlates with responsiveness to immunotherapy. The study highlights the strong immuno‐evasive ability of METTL5 as a promising therapeutic target in ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery, Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- Department of Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
ORCID-Profile: Sui Peng
Förderung
- National Key Research and Development Program
- State Key Program of National Natural Science of China
- National Natural Science Foundation of China
- the National Science Fund for Young Scholars
- Fundamental Research Funds for the Central Universities
- Youth S&T Talent Support Programme of Guangdong Provincial Association for Science and Technology
- Kelin Foundation for Distinguished Young Scholars
- National Key Research and Development Program of China
Zitieren
APA
Li, S., Zhao, X., Song, T., Chen, Q., Wu, Y., Zhang, Y., Chen, J., Wu, Y., Li, B., Zhang, X., Dai, Z., Xu, L., Xie, Y., Cheng, A. S., Guo, J., Kuang, M., Lin, S., Peng, Z., Peng, S., & Zeng, X. (2026). METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation. Advanced Science, 13(11). https://doi.org/10.1002/advs.202512528
Vancouver
Li S, Zhao X, Song T, Chen Q, Wu Y, Zhang Y, et al. METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation. Advanced Science. 2026;13(11). doi:10.1002/advs.202512528
BibTeX
@article{Li2026,
author = {Li, Shuang and Zhao, Xiao and Song, Tongtong and Chen, Qiaoyi and Wu, Yanqing and Zhang, Yuting and Chen, Jingying and Wu, Yifan and Li, Bin and Zhang, Xinyue and Dai, Zihao and Xu, Lixia and Xie, Yubin and Cheng, Alfred Sze-Lok and Guo, Jianping and Kuang, Ming and Lin, Shuibin and Peng, Zhenwei and Peng, Sui and Zeng, Xuezhen},
title = {METTL5 Enables Immune Evasion of Liver Cancer via Chemokine mRNA Translation Regulation},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {11},
doi = {10.1002/advs.202512528}
}
EUVIMED